Scarica l'app Stockscreener
1,040.00
0.17%
1.73
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LLY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Lilly Eli Co Borsa (LLY) Ultime notizie
CRISPR Therapeutics Spotlights Momentum For Lead Gene Therapy As Adoption Widens - Benzinga
Eli Lilly (LLY) Prepares Orforglipron Inventory Ahead of FDA Dec - GuruFocus
Did Eli Lilly Just Make a Deal for Its Next Blockbuster Drug? - The Motley Fool
Eli Lilly (LLY) Retains Buy Rating on Strong 2026 Outlook - Insider Monkey
Eli Lilly and Company (LLY) Gets Upgraded to Buy From Hold by Freedom Capital - Finviz
Eli Lilly and Company (NYSE:LLY) Stock Price Expected to Rise, CICC Research Analyst Says - MarketBeat
Eli Lilly builds $1.5 billion stockpile of weight-loss pill ahead of FDA decision - Reuters
Rx Rundown: Eli Lilly, Supreme Group, Regenxbio and more - Medical Marketing and Media
Eli Lilly boosts weight loss pill inventory ahead of FDA decision - Seeking Alpha
Eli Lilly and Company $LLY Shares Bought by Public Sector Pension Investment Board - MarketBeat
Eli Lilly Builds $1.5 Billion Inventory Of Experimental Weight-Loss Pill As FDA Decision Looms - Benzinga
City Council approves $6 billion Eli Lilly plant, addresses recycling issues - WAFF
Lilly Stock Upgraded to Strong Buy as Growth Momentum and RNA Therapeutics Bet Take Center Stage - AD HOC NEWS
Eli Lilly Uses GLP 1 Cash Flows To Pursue Next Wave RNA Therapies - simplywall.st
ELI LILLY & Co SEC 10-K Report - TradingView
Eli Lilly Stock (LLY) Gets New ‘Buy Rating’ After Strong Earnings - TipRanks
Lilly’s $2.4B bet on off-the-shelf cell therapy is part of a wider Big Pharma shift - PharmaVoice
Eli Lilly and Company $LLY Stock Position Increased by Varma Mutual Pension Insurance Co - MarketBeat
How to Play Eli Lilly Stock Following a Robust Q4 Earnings Report - Nasdaq
Savvy Advisors Inc. Has $7.36 Million Position in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2026-2030 (Jan 2026) - 24/7 Wall St.
Eli Lilly and Company (NYSE:LLY) Stock Rating Upgraded by Freedom Capital - MarketBeat
Eli Lilly Extends Lead in Weight-Loss Drug Market - AD HOC NEWS
Fund Update: 382,112 ELI LILLY (LLY) shares added to PARNASSUS INVESTMENTS, LLC portfolio - Quiver Quantitative
Illinois Municipal Retirement Fund Sells 1,002 Shares of Eli Lilly and Company $LLY - MarketBeat
Eli Lilly vs Novo Nordisk in the Weight Loss Drug Market: Here's What Investors Need to Know. - Yahoo Finance
Atria Investments Inc Has $30.79 Million Stake in Eli Lilly and Company $LLY - MarketBeat
Is Eli Lilly and Company (NYSE:LLY) Strengthening its Position In S&P 500 Futures - Kalkine Media
Eli Lilly Leadership Receives Stock Awards Amid Strong Growth Forecast - AD HOC NEWS
Eli Lilly and Company (LLY) to Acquire Orna Therapeutics in $2.4B Deal to Expand RNA Pipeline - Insider Monkey
7th Circ. Mulls Expiration Date Of Teva, Eli Lilly Patent Deal - Law360
Novo to Follow Lilly and Sell Obesity Shot Wegovy in Vials - Bloomberg.com
Top Analyst Reports for Eli Lilly, Marriott & Fortinet - TradingView
Robust Demand for Eli Lilly and Company (LLY)'s Obesity and Diabetes Treatments Drives Strong Investor Sentiment - Finviz
Robust Demand for Eli Lilly and Company (LLY)’s Obesity and Diabetes Treatments Drives Strong Investor Sentiment - Yahoo Finance
3 Reasons to Buy Eli Lilly Stock - Yahoo Finance
Novo Nordisk Reportedly Eyes Launching Wegovy In Vials To Compete With Rival Eli Lilly - Stocktwits
Ex-Dividend Reminder: Bio-Techne, 3M and Eli Lilly - Nasdaq
Eli Lilly and Company $LLY Shares Bought by Westbourne Investments Inc. - MarketBeat
Krilogy Financial LLC Acquires Shares of 4,276 Eli Lilly and Company $LLY - MarketBeat
Mechanics Financial Corp Has $1.98 Million Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly and Company $LLY Shares Sold by Rhumbline Advisers - MarketBeat
Eli Lilly and Company $LLY Stock Position Raised by Madison Asset Management LLC - MarketBeat
Stratos Wealth Partners LTD. Grows Position in Eli Lilly and Company $LLY - MarketBeat
Eli Lilly and Company $LLY Shares Acquired by Jensen Investment Management Inc. - MarketBeat
The Top 5 Analyst Questions From Eli Lilly's Q4 Earnings Call - Finviz
CICC Adjusts Price Target on Eli Lilly and Co. to $1,107 From $1,060, Maintains Neutral Rating - marketscreener.com
Cibc World Market Inc. Buys 49,634 Shares of Eli Lilly and Company $LLY - MarketBeat
61,694 Shares in Eli Lilly and Company $LLY Acquired by Caprock Group LLC - MarketBeat
ING Groep NV Buys 132,234 Shares of Eli Lilly and Company $LLY - MarketBeat
Eli Lilly buys Orna Therapeutics for US$2.4bn - Health Tech World
Impax Asset Management Group plc Has $45.27 Million Stock Holdings in Eli Lilly and Company $LLY - MarketBeat
Lilly's bowel disease drug gets approval in China - marketscreener.com
Eli Lilly Broadens Genetic Medicine Portfolio While Shares Screen As Undervalued - Yahoo Finance
Eli Lilly: Mirikizumab approved in China for treatment of moderate-to-severe Crohn's disease and ulcerative colitisCo statement - marketscreener.com
Fisher Asset Management Boosts Eli Lilly Stake by 153K Shares - TipRanks
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. - Yahoo Finance
This Week's Healthcare Earnings: Lilly, Cigna And More - Law360
Eli Lilly expansion poised to reshape Lehigh Valley housing market - WFMZ.com
Eli Lilly stock upgraded to Buy at Freedom Capital on strong growth outlook - Investing.com Canada
Beyond Obesity: Lilly Inks Up to $11.25B in Cancer, Immune System DealsGEN - GEN - Genetic Engineering and Biotechnology News
LLY Stock Quote Price and Forecast - CNN
0.45%
1.76%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):